177lu-psma-617
novartis
['pcsm', 'crpc', 'prostate']
psma-pet criteria identified to optimize mcrpc patient selection for 177lu-psma-617 #asco22 #urology #urologist #pcsm #prostatecancer 
Expert clinical analysis. Practice advice. Policy perspectives.